{"id":93348,"date":"2025-07-26T06:00:18","date_gmt":"2025-07-26T06:00:18","guid":{"rendered":"https:\/\/www.europesays.com\/us\/93348\/"},"modified":"2025-07-26T06:00:18","modified_gmt":"2025-07-26T06:00:18","slug":"precise-genetic-analysis-with-epicgen-solid-cancer-msi-kit-genovesa-software-solution-included","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/93348\/","title":{"rendered":"Precise Genetic Analysis with epicGEN Solid Cancer &#038; MSI Kit\u202f (GENOVESA Software Solution Included)"},"content":{"rendered":"<p>Newswise \u2014 Highly sensitive and efficient analysis with an emphasis on specific regions of the genome. epicGEN NGS panels are designed for modern diagnostic laboratories. The epicGEN Solid Cancer &amp; MSI Kit provides a comprehensive solution for oncology diagnostics, including MSI analysis without the need to use healthy tissue.<\/p>\n<p>Get to know epicGEN \u2013 next-generation NGS panels for precise genome analysis. The new epicGEN Solid Cancer &amp; MSI Kit is designed for targeted analysis of 42 genes relevant for the diagnostics of solid tumors and the detection of genetic changes (InDel, SNP, CNV and MSI).<\/p>\n<p>How epicGEN panels work<\/p>\n<p><a href=\"https:\/\/www.biovendor.com\/next-generation-sequencing-ngs?utm_source=media-centre&amp;utm_medium=clanek&amp;utm_campaign=epicGEN-launch#epicgen-kits\" rel=\"nofollow noopener\" target=\"_blank\">epicGEN panels<\/a>\u00a0utilize NGS (Next-Generation Sequencing) technology, which is based on the hybridization enrichment method, which allows for selective capture of target DNA segments prior to sequencing.<br \/>Precisely designed probes are essential \u2013 they ensure high specificity, even coverage, and efficient detection of mutations even in low-quality samples.\u00a0Compared to traditional DNA analysis methods, these panels save time, capacity, and provide more accurate results. epicGEN can be used by experts in the fields of oncology, hereditary disease testing, or pharmacogenomics.<\/p>\n<p>epicGEN Solid Cancer &amp; MSI Kit for oncological diagnostics<\/p>\n<p>The\u00a0<a href=\"https:\/\/www.biovendor.com\/epicgen-solid-cancer--msi-kit\" rel=\"nofollow noopener\" target=\"_blank\"><strong>epicGEN Solid Cancer &amp; MSI Kit panel<\/strong><\/a>\u00a0enables the precise diagnostics of solid tumors and the detection of various types of genetic changes.\u00a0<br \/>This panel is fully covered by health insurance companies in the Czech Republic and its integration into clinical practice is easy.<br \/>\u00a0<br \/>These are the key features:<\/p>\n<ul>\n<li aria-level=\"1\"><strong>Targeted analysis of 42 genes<\/strong>\u00a0\u2013 panel focused on the diagnostics of solid tumors (InDel, SNP, CNV and MSI).<\/li>\n<\/ul>\n<ul>\n<li aria-level=\"1\"><strong>Effective detection of somatic mutation<\/strong>s \u2013 sensitivity down to 1% of tumor cells.<\/li>\n<\/ul>\n<ul>\n<li aria-level=\"1\"><strong>The possibility to analyze difficult samples<\/strong>\u00a0\u2013 works even with small amounts or degraded DNA (from 1 ng).<\/li>\n<\/ul>\n<ul>\n<li aria-level=\"1\"><strong>Easy integration into laboratory practice<\/strong>\u00a0\u2013 compatible with common sequencing platforms.<\/li>\n<\/ul>\n<ul>\n<li aria-level=\"1\"><strong>Connection with GENOVESA software<\/strong>\u00a0\u2013 intuitive bioinformatics solution for data analysis and interpretation.<\/li>\n<\/ul>\n<p>GENOVESA software: Simple NGS data analysis<\/p>\n<p>epicGEN panels are integrated into the\u00a0<a href=\"https:\/\/www.genovesa.biovendor.group\/\" rel=\"nofollow noopener\" target=\"_blank\"><strong>GENOVESA bioinformatics software<\/strong><\/a>, which simplifies the interpretation of results. The user-friendly environment enables quick analysis and clear visualization of genetic variants, which makes the work of laboratory specialists easier.<br \/>In the case of MSI analysis, the baseline is established using normal MS-Stable samples, which simplifies diagnostics. In addition, the results are clearly displayed graphically \u2013 this facilitates interpretation, allows visual assessment of each locus, and provides advanced control over sample evaluation.<br \/>\u00a0<br \/><strong>Would you like to know more?<\/strong><br \/>Contact us for more detailed information about the epicGEN product line. We are\u00a0<a href=\"https:\/\/www.biovendor.group\/our-brands#biovendor-mdx\" rel=\"nofollow noopener\" target=\"_blank\"><strong>BioVendor MDx<\/strong><\/a>\u00a0\u2013 we bring to the market diagnostic tools for innovative methods of molecular diagnostics from BioVendor Group laboratories.<\/p>\n<p>Contact our product manager<\/p>\n<p>Iveta T\u00f3thov\u00e1, PhD.<br \/>Product &amp; Scientific Manager<br \/>+420 724 873 015<br \/><a href=\"http:\/\/www.newswise.com\/cdn-cgi\/l\/email-protection#c3b7acb7abacb5a283a1aaacb5a6ada7acb1eeaea7bbeda0acae\" rel=\"nofollow noopener\" target=\"_blank\">[email\u00a0protected]<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Newswise \u2014 Highly sensitive and efficient analysis with an emphasis on specific regions of the genome. epicGEN NGS&hellip;\n","protected":false},"author":3,"featured_media":91471,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[61713,61714,61717,61712,3653,235,815,61715,1941,159,61716,67,132,68],"class_list":{"0":"post-93348","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-genetics","8":"tag-71st-aacc-annual-scientific-meeting-clinical-lab-expo","9":"tag-72nd-aacc-annual-scientific-meeting-clinical-lab-expo","10":"tag-adlm-2025-press-program","11":"tag-adlm-2025genome-analysisdiagnostic-equipmentdna-sequencingbioinformatics","12":"tag-biotech","13":"tag-cancer","14":"tag-genetics","15":"tag-medical-meetings","16":"tag-newswise","17":"tag-science","18":"tag-scientific-meetings","19":"tag-united-states","20":"tag-unitedstates","21":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/114918013307815155","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/93348","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=93348"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/93348\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/91471"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=93348"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=93348"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=93348"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}